These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36642873)

  • 1. Therapeutic Potential of Herbal Medicine against Non-alcoholic Fatty Liver Disease.
    Pourali G; Hosseini ZS; Maftooh M; Nazari E; Khazaei M; Nassiri M; Hassanian SM; Ghayour-Mobarhan M; Ferns GA; Kiani MA; Avan A
    Curr Drug Targets; 2023; 24(4):300-319. PubMed ID: 36642873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicinal plants and bioactive natural compounds in the treatment of non-alcoholic fatty liver disease: A clinical review.
    Bagherniya M; Nobili V; Blesso CN; Sahebkar A
    Pharmacol Res; 2018 Apr; 130():213-240. PubMed ID: 29287685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herbal medicines and nonalcoholic fatty liver disease.
    Yao H; Qiao YJ; Zhao YL; Tao XF; Xu LN; Yin LH; Qi Y; Peng JY
    World J Gastroenterol; 2016 Aug; 22(30):6890-905. PubMed ID: 27570425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phytotherapy as Multi-Hit Therapy to Confront the Multiple Pathophysiology in Non-Alcoholic Fatty Liver Disease: A Systematic Review of Experimental Interventions.
    Ore A; Akinloye OA
    Medicina (Kaunas); 2021 Aug; 57(8):. PubMed ID: 34441028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An in vitro and in vivo study of a 4-herb formula on the management of diet-induced metabolic syndrome.
    Wat E; Wang Y; Chan K; Law HW; Koon CM; Lau KM; Leung PC; Yan C; Lau CBS
    Phytomedicine; 2018 Mar; 42():112-125. PubMed ID: 29655677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Daesiho-tang on obesity with non-alcoholic fatty liver disease: a study protocol for a randomised, double-blind, placebo-controlled pilot trial.
    Han K; Kwon O; Park HJ; Jung SY; Yang C; Son CG
    Trials; 2020 Jan; 21(1):128. PubMed ID: 32005283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Potential of Lamiaceae Herbs for Mitigation of Overweight, Obesity, and Fatty Liver: Studies and Perspectives.
    Diab F; Zbeeb H; Baldini F; Portincasa P; Khalil M; Vergani L
    Molecules; 2022 Aug; 27(15):. PubMed ID: 35956991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventive and therapeutic effects of natural products and herbal extracts on nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Cao Y; Fang X; Sun M; Zhang Y; Shan M; Lan X; Zhu D; Luo H
    Phytother Res; 2023 Sep; 37(9):3867-3897. PubMed ID: 37449926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural Active Compounds from Plant Food and Chinese Herbal Medicine for Nonalcoholic Fatty Liver Disease.
    Liu Q; Zhu L; Cheng C; Hu YY; Feng Q
    Curr Pharm Des; 2017; 23(34):5136-5162. PubMed ID: 28925892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omega-3 fatty acids: Mechanisms of benefit and therapeutic effects in pediatric and adult NAFLD.
    Nobili V; Alisi A; Musso G; Scorletti E; Calder PC; Byrne CD
    Crit Rev Clin Lab Sci; 2016; 53(2):106-20. PubMed ID: 26463349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chinese Medicinal Herbs Targeting the Gut-Liver Axis and Adipose Tissue-Liver Axis for Non-Alcoholic Fatty Liver Disease Treatments: The Ancient Wisdom and Modern Science.
    Zhang S; Wong YT; Tang KY; Kwan HY; Su T
    Front Endocrinol (Lausanne); 2020; 11():572729. PubMed ID: 33101207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effect of anti-diabetic drugs for nonalcoholic fatty liver disease.
    Kim KS; Lee BW
    Clin Mol Hepatol; 2020 Oct; 26(4):430-443. PubMed ID: 32791578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement.
    Athyros VG; Alexandrides TK; Bilianou H; Cholongitas E; Doumas M; Ganotakis ES; Goudevenos J; Elisaf MS; Germanidis G; Giouleme O; Karagiannis A; Karvounis C; Katsiki N; Kotsis V; Kountouras J; Liberopoulos E; Pitsavos C; Polyzos S; Rallidis LS; Richter D; Tsapas AG; Tselepis AD; Tsioufis K; Tziomalos K; Tzotzas T; Vasiliadis TG; Vlachopoulos C; Mikhailidis DP; Mantzoros C
    Metabolism; 2017 Jun; 71():17-32. PubMed ID: 28521870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD).
    Rong L; Zou J; Ran W; Qi X; Chen Y; Cui H; Guo J
    Front Endocrinol (Lausanne); 2022; 13():1087260. PubMed ID: 36726464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between non-alcoholic fatty liver disease and colorectal cancer.
    Parizadeh SM; Parizadeh SA; Alizade-Noghani M; Jafarzadeh-Esfehani R; Ghandehari M; Mottaghi-Moghaddam A; Goldani F; Khazaei M; Ghayour-Mobarhan M; Ferns GA; Hassanian SM; Avan A
    Expert Rev Gastroenterol Hepatol; 2019 Jul; 13(7):633-641. PubMed ID: 31092057
    [No Abstract]   [Full Text] [Related]  

  • 16. Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver disease.
    Federico A; Zulli C; de Sio I; Del Prete A; Dallio M; Masarone M; Loguercio C
    World J Gastroenterol; 2014 Dec; 20(45):16841-57. PubMed ID: 25492998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contributions of Indian Council of Medical Research (ICMR) in the area of Medicinal plants/Traditional medicine.
    Tandon N; Yadav SS
    J Ethnopharmacol; 2017 Feb; 197():39-45. PubMed ID: 27452657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.
    Faghihzadeh F; Adibi P; Hekmatdoost A
    Br J Nutr; 2015 Sep; 114(5):796-803. PubMed ID: 26234526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioactive Components and Possible Activities of Medicinal Mushrooms in Alleviating the Pathogenesis of Nonalcoholic Fatty Liver Disease (Review).
    Lo HC
    Int J Med Mushrooms; 2021; 23(3):29-41. PubMed ID: 33822497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An unbiased lipidomics approach identifies key lipid molecules as potential therapeutic targets of Dohongsamul-tang against non-alcoholic fatty liver diseases in a mouse model of obesity.
    Park SH; Lee JE; Lee SM; Lee J; Seo CS; Hwang GS; Jung J
    J Ethnopharmacol; 2020 Oct; 260():112999. PubMed ID: 32454173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.